Scholarship 15/14283-0 - Sepse, Imunofarmacologia - BV FAPESP
Advanced search
Start date
Betweenand

Role of enzyme Indoleamine 2, 3-dioxygenase (IDO) in the development of sepsis-induced immunosuppression

Grant number: 15/14283-0
Support Opportunities:Scholarships abroad - Research Internship - Doctorate
Start date until: September 11, 2015
End date until: March 01, 2016
Field of knowledge:Biological Sciences - Pharmacology
Principal Investigator:José Carlos Farias Alves Filho
Grantee:Raphael Gomes Ferreira
Supervisor: Francesca Fallarino
Host Institution: Faculdade de Medicina de Ribeirão Preto (FMRP). Universidade de São Paulo (USP). Ribeirão Preto , SP, Brazil
Institution abroad: Università degli Studi di Perugia, Italy  
Associated to the scholarship:12/11312-0 - Role of enzyme indoleamine 2, 3-dioxygenase (IDO) in the development of sepsis-induced immunosuppression, BP.DR

Abstract

Sepsis is a systemic inflammatory response generated as a result of an infection, often leading to the development of a framework of delayed immunosuppression which may continue for years after the patient was released from hospital. The mechanisms involved in the development of sepsis-induced immunosuppression remain poor understood, but it is known that an increase in the number of regulatory T lymphocytes (Tregs) is involved in the maintenance of this state. Moreover, some works have shown tolerogenic and immunomodulatory roles for the enzyme indoleamine 2,3-dioxygenase (IDO). This enzyme is expressed in different cells of the immune system, including macrophages and dendritic cells, after activation by bacterial components, such as lipopolysaccharide (LPS) and CpG, as well as interferons (IFN)-±, ² and Ò. When activated, IDO initiates the kynurenine pathway of tryptophan degradation, which has been implicated in promoting Treg generation. Despite the role of IDO on immune system regulation, there are no studies in literature about its role in the development of sepsis-induced immunosuppression. Thus, this project aims to investigate: a) the IDO expression during immunosuppression development; b) the role of IDO on Treg development; and c) role of IDO in the susceptibility to secondary infection in animals that survive sepsis.

News published in Agência FAPESP Newsletter about the scholarship:
More itemsLess items
Articles published in other media outlets ( ):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Please report errors in scientific publications list using this form.